Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Prudential Financial
PRU
$42.9B
| $2.14M | ﹤0.01% |
24,205
-2,431,921
| -99% | -$203M |
|
1402
TransDigm Group
TDG
$71B
| $2.12M | ﹤0.01% |
2,369
+537
| +29% | +$425K |
|
1403
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.8B
| $2.11M | ﹤0.01% |
31,780
-311,336
| -91% | -$20.8M |
|
1404
Quanta Services
PWR
$105B
| $2.11M | ﹤0.01% |
10,718
+1,547
| +17% | +$270K |
|
1405
Exelixis
EXEL
$14.1B
| $2.06M | ﹤0.01% |
107,837
+20,052
| +23% | +$386K |
|
|
FLNT
1406
Fluent
FLNT
$106M
| $2.05M | ﹤0.01% |
544,700
-157,233
| -22% | -$661K |
|
1407
Norfolk Southern
NSC
$76.6B
| $2.04M | ﹤0.01% |
9,008
+1,440
| +19% | +$306K |
|
1408
Tyler Technologies
TYL
$12.8B
| $1.99M | ﹤0.01% |
4,780
+1,663
| +53% | +$640K |
|
1409
Grupo Cibest SA
CIB
$21.3B
| $1.97M | ﹤0.01% |
73,676
-120,810
| -62% | -$3.15M |
|
|
PLL
1410
DELISTED
Piedmont Lithium
PLL
| $1.93M | ﹤0.01% |
33,402
+382
| +1% | +$21.9K |
|
1411
Disc Medicine
IRON
$3.01B
| $1.92M | ﹤0.01% |
+43,270
| New | +$1.54M |
|
1412
Regal Rexnord
RRX
$14.7B
| $1.92M | ﹤0.01% |
12,452
-4,081
| -25% | -$556K |
|
1413
Capital City Bank Group
CCBG
$904M
| $1.91M | ﹤0.01% |
+62,212
| New | +$1.88M |
|
1414
AutoNation
AN
$7.15B
| $1.91M | ﹤0.01% |
11,573
-8,383
| -42% | -$1.16M |
|
1415
Adicet Bio
ACET
$86.8M
| $1.89M | ﹤0.01% |
48,519
+17,155
| +55% | +$1.51M |
|
1416
Theravance Biopharma
TBPH
$874M
| $1.89M | ﹤0.01% |
182,260
+41,999
| +30% | +$464K |
|
|
GPGI
1417
GPGI Inc
GPGI
$4.51B
| $1.86M | ﹤0.01% |
327,148
-157,209
| -32% | -$942K |
|
1418
GrafTech
EAF
$201M
| $1.86M | ﹤0.01% |
36,887
-6,895
| -16% | -$321K |
|
1419
VanEck Junior Gold Miners ETF
GDXJ
$7.34B
| $1.86M | ﹤0.01% |
+52,026
| New | +$2.02M |
|
1420
iShares MSCI Poland ETF
EPOL
$754M
| $1.84M | ﹤0.01% |
95,994
| – | – |
|
|
BLUE
1421
DELISTED
bluebird bio
BLUE
| $1.83M | ﹤0.01% |
27,780
+16,262
| +141% | +$1.19M |
|
1422
Interactive Brokers
IBKR
$39.7B
| $1.83M | ﹤0.01% |
88,016
+52,252
| +146% | +$1.03M |
|
1423
Teva Pharmaceuticals
TEVA
$40B
| $1.82M | ﹤0.01% |
242,326
+46,712
| +24% | +$379K |
|
1424
Coastal Financial
CCB
$682M
| $1.81M | ﹤0.01% |
47,949
-22,282
| -32% | -$796K |
|
1425
Stoke Therapeutics
STOK
$2.01B
| $1.8M | ﹤0.01% |
169,288
-31,609
| -16% | -$336K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.